310 related articles for article (PubMed ID: 19166511)
21. PINK1 defect causes mitochondrial dysfunction, proteasomal deficit and alpha-synuclein aggregation in cell culture models of Parkinson's disease.
Liu W; Vives-Bauza C; Acín-Peréz- R; Yamamoto A; Tan Y; Li Y; Magrané J; Stavarache MA; Shaffer S; Chang S; Kaplitt MG; Huang XY; Beal MF; Manfredi G; Li C
PLoS One; 2009; 4(2):e4597. PubMed ID: 19242547
[TBL] [Abstract][Full Text] [Related]
22. Axonal pathology in hPSC-based models of Parkinson's disease results from loss of Nrf2 transcriptional activity at the Map1b gene locus.
Czaniecki C; Ryan T; Stykel MG; Drolet J; Heide J; Hallam R; Wood S; Coackley C; Sherriff K; Bailey CDC; Ryan SD
Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14280-14289. PubMed ID: 31235589
[TBL] [Abstract][Full Text] [Related]
23. The Parkinson's disease-associated gene PINK1 protects neurons from ischemic damage by decreasing mitochondrial translocation of the fission promoter Drp1.
Zhao Y; Chen F; Chen S; Liu X; Cui M; Dong Q
J Neurochem; 2013 Dec; 127(5):711-22. PubMed ID: 23772688
[TBL] [Abstract][Full Text] [Related]
24. miR-27a and miR-27b regulate autophagic clearance of damaged mitochondria by targeting PTEN-induced putative kinase 1 (PINK1).
Kim J; Fiesel FC; Belmonte KC; Hudec R; Wang WX; Kim C; Nelson PT; Springer W; Kim J
Mol Neurodegener; 2016 Jul; 11(1):55. PubMed ID: 27456084
[TBL] [Abstract][Full Text] [Related]
25. Leucine-rich repeat kinase 2 disturbs mitochondrial dynamics via Dynamin-like protein.
Niu J; Yu M; Wang C; Xu Z
J Neurochem; 2012 Aug; 122(3):650-8. PubMed ID: 22639965
[TBL] [Abstract][Full Text] [Related]
26. Depletion of PINK1 affects mitochondrial metabolism, calcium homeostasis and energy maintenance.
Heeman B; Van den Haute C; Aelvoet SA; Valsecchi F; Rodenburg RJ; Reumers V; Debyser Z; Callewaert G; Koopman WJ; Willems PH; Baekelandt V
J Cell Sci; 2011 Apr; 124(Pt 7):1115-25. PubMed ID: 21385841
[TBL] [Abstract][Full Text] [Related]
27. PINK1 suppresses alpha-synuclein-induced neuronal injury: a novel mechanism in protein phosphatase 2A activation.
Yang W; Wang X; Liu J; Duan C; Gao G; Lu L; Yu S; Yang H
Oncotarget; 2018 Jan; 9(1):37-53. PubMed ID: 29416594
[TBL] [Abstract][Full Text] [Related]
28. Quantitative expression proteomics and phosphoproteomics profile of brain from PINK1 knockout mice: insights into mechanisms of familial Parkinson's disease.
Triplett JC; Zhang Z; Sultana R; Cai J; Klein JB; Büeler H; Butterfield DA
J Neurochem; 2015 Jun; 133(5):750-65. PubMed ID: 25626353
[TBL] [Abstract][Full Text] [Related]
29. PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death.
Gandhi S; Wood-Kaczmar A; Yao Z; Plun-Favreau H; Deas E; Klupsch K; Downward J; Latchman DS; Tabrizi SJ; Wood NW; Duchen MR; Abramov AY
Mol Cell; 2009 Mar; 33(5):627-38. PubMed ID: 19285945
[TBL] [Abstract][Full Text] [Related]
30. PINK1 protein in normal human brain and Parkinson's disease.
Gandhi S; Muqit MM; Stanyer L; Healy DG; Abou-Sleiman PM; Hargreaves I; Heales S; Ganguly M; Parsons L; Lees AJ; Latchman DS; Holton JL; Wood NW; Revesz T
Brain; 2006 Jul; 129(Pt 7):1720-31. PubMed ID: 16702191
[TBL] [Abstract][Full Text] [Related]
31. Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease.
Lasser-Katz E; Simchovitz A; Chiu WH; Oertel WH; Sharon R; Soreq H; Roeper J; Goldberg JA
J Neurosci; 2017 Jan; 37(1):47-57. PubMed ID: 28053029
[TBL] [Abstract][Full Text] [Related]
32. Linking alpha-synuclein phosphorylation to reactive oxygen species formation and mitochondrial dysfunction in SH-SY5Y cells.
Perfeito R; Lázaro DF; Outeiro TF; Rego AC
Mol Cell Neurosci; 2014 Sep; 62():51-9. PubMed ID: 25109238
[TBL] [Abstract][Full Text] [Related]
33. PINK1-mediated phosphorylation of LETM1 regulates mitochondrial calcium transport and protects neurons against mitochondrial stress.
Huang E; Qu D; Huang T; Rizzi N; Boonying W; Krolak D; Ciana P; Woulfe J; Klein C; Slack RS; Figeys D; Park DS
Nat Commun; 2017 Nov; 8(1):1399. PubMed ID: 29123128
[TBL] [Abstract][Full Text] [Related]
34. Mutation of hop-1 and pink-1 attenuates vulnerability of neurotoxicity in C. elegans: the role of mitochondria-associated membrane proteins in Parkinsonism.
Wu S; Lei L; Song Y; Liu M; Lu S; Lou D; Shi Y; Wang Z; He D
Exp Neurol; 2018 Nov; 309():67-78. PubMed ID: 30076829
[TBL] [Abstract][Full Text] [Related]
35. Alpha-synuclein impairs normal dynamics of mitochondria in cell and animal models of Parkinson's disease.
Xie W; Chung KK
J Neurochem; 2012 Jul; 122(2):404-14. PubMed ID: 22537068
[TBL] [Abstract][Full Text] [Related]
36. Nix restores mitophagy and mitochondrial function to protect against PINK1/Parkin-related Parkinson's disease.
Koentjoro B; Park JS; Sue CM
Sci Rep; 2017 Mar; 7():44373. PubMed ID: 28281653
[TBL] [Abstract][Full Text] [Related]
37. Mitochondrial division inhibitor-1 is neuroprotective in the A53T-α-synuclein rat model of Parkinson's disease.
Bido S; Soria FN; Fan RZ; Bezard E; Tieu K
Sci Rep; 2017 Aug; 7(1):7495. PubMed ID: 28790323
[TBL] [Abstract][Full Text] [Related]
38. Mitochondrial localization of alpha-synuclein protein in alpha-synuclein overexpressing cells.
Shavali S; Brown-Borg HM; Ebadi M; Porter J
Neurosci Lett; 2008 Jul; 439(2):125-8. PubMed ID: 18514418
[TBL] [Abstract][Full Text] [Related]
39. Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice.
Lee MK; Stirling W; Xu Y; Xu X; Qui D; Mandir AS; Dawson TM; Copeland NG; Jenkins NA; Price DL
Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8968-73. PubMed ID: 12084935
[TBL] [Abstract][Full Text] [Related]
40. Cell metabolism affects selective vulnerability in PINK1-associated Parkinson's disease.
Yao Z; Gandhi S; Burchell VS; Plun-Favreau H; Wood NW; Abramov AY
J Cell Sci; 2011 Dec; 124(Pt 24):4194-202. PubMed ID: 22223879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
